| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/25/2008 | US20080233651 Method and medicament for inhibiting the expression of a given gene |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233645 Methods and Compositions of Ig20 and Denn-Sv Splice Variants |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233595 Method for diagnosing intertility |
| 09/25/2008 | US20080233581 Nucleic acid; use identifying the enzyme inhibitors which are used as antitumor agents; detection of cells expressing the enzyme |
| 09/25/2008 | US20080233562 dividing cells into histone deacetylase inhibitor sensitive and histone deacetylase inhibitor resistant cell; selecting gene showing high expression in sensitive tumor cell and low expression in resistant tumor cell or vice versa; provides gene for predicting efficacy of histone deacetylase inhibitor |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233211 Aqueous composition of sodium selenite and hydrocortisone; sepsis, Systemic Inflammatory Response Sydndrome, and/or septic shock |
| 09/25/2008 | US20080233206 Compositions and methods for anti-inflammatory treatments |
| 09/25/2008 | US20080233201 Method for Preparing Calibrated Biodegradable Microspheres |
| 09/25/2008 | US20080233199 Forming a coacervate of an active agent, a biocompatible polymer and a solvent; combining with a quench liquid forming microparticles containing the active agent; adding a second coacervation agent |
| 09/25/2008 | US20080233198 Administering microcapsules containing a peptide and copolymer incorporating triethyl citrate, tributyl citrate or acetyl tributyl citrate; reducing initial release, providing steady release over time |
| 09/25/2008 | US20080233194 Stabilized ; dispersion in dispersion microstructure; administering to lungs |
| 09/25/2008 | US20080233170 Glycosylated peptides having osteogenic activity; inducing bone formation, vascularization, mineralization, bone marrow differentiation |
| 09/25/2008 | US20080233149 Use of Erythropoietin for Enhancing Immune Responses and for Treatment of Lymphoproliferative Disorders |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233138 Coccidiosis Poultry Vaccine |
| 09/25/2008 | US20080233137 Block the inflammatory and immunomodulatory activity mediated by endogenous C5a; Adult Respiratory Distress Syndrome (ARDS), severe tissue damage following thrombotic events such as heart attacks and stroke, inflammatory bowel diseases and rheumatoid arthritis |
| 09/25/2008 | US20080233136 Biologically Active Peptides |
| 09/25/2008 | US20080233132 Immunotherapy with myelin repair; immunoglobulins; autoimmune disorders |
| 09/25/2008 | US20080233126 G Proteins, Polynucleotides Encoding the Same and Utilization Thereof |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233114 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 09/25/2008 | US20080233113 Cardiovascular conditions, ischemia-reperfusion injury, atherosclerosis, inflammatory gastrointestinal disorder, pulmonary condition, musculoskeletal conditions, renal conditions, skin conditions, organ or tissue transplants, nervous system disorders |
| 09/25/2008 | US20080233108 Methods for detecting and inhibiting angiogenesis using antagonists |
| 09/25/2008 | US20080233107 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide |
| 09/25/2008 | US20080233103 Mycobacterial peptide deformylase |
| 09/25/2008 | US20080233102 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity |
| 09/25/2008 | US20080233101 RNA-mediated epigenetic regulation of gene transcription |
| 09/25/2008 | US20080233100 Targeted enzymes |
| 09/25/2008 | US20080233099 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 09/25/2008 | US20080233098 For regulation of growth of neurons in the Central Nervous System; delivering a dominant negative RhoA to the nerve growth environment of the patient, stimulating axon growth of a damaged neuronal axon; exoenzyme C3( ADP-ribosyltransferase) or Y27632 |
| 09/25/2008 | US20080233097 different phosphorylation site is the threonine residue in position 123 (Thr123) of mouse or human p38, alpha isoform; diagnostic marker of pathologies mediated by MAPKs |
| 09/25/2008 | US20080233096 transaminase, dehydrogenase, decarboxylase, ligase as glutamate modifying enzymes and oxaloacetate, pyruvate, NAD+, NADP+, 2-oxohexanedioic acid, 2-oxo-3-sulfopropionate, 2-oxo-3-sulfinopropionic acid, 2-oxo-3-phenylpropionic acid co-factors to enhance brain to blood efflux |
| 09/25/2008 | US20080233085 Use of Il-18Bp Isoforms for the Treatment and/or Prevention of Neurological Inflammatory Diseases |
| 09/25/2008 | US20080233084 providing a protected immobilised Interleukin-8; coupling hydrazinonicotinic acid to immobilised Interleukin-8; deprotecting the HYNIC-conjugated Interleukin-8; cleavage of deprotected HYNIC-conjugated Interleukin-8 from a solid support |
| 09/25/2008 | US20080233083 Methods and Compositions for Vaccination of Animals with Prrsv Antigens with Improved Immunogenicity |
| 09/25/2008 | US20080233082 Glycolic acid-lactic acid biodegradable copolymer incorporating signaling factors that signal the repair of vascular stem cells (factors such as ICAM, VCAM, VEGF, CXCR4, matrix metalloproteinases, CTGF, angiogenin, angiopoietin-1, fibroblast growth factors (FGFs), follistatin, G-CSF etc. stents |
| 09/25/2008 | US20080233081 Pro-angiogenic peptides |
| 09/25/2008 | US20080233053 Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients |
| 09/25/2008 | US20080233050 Using cyanine dyes; in situ supplying to tumor cells |
| 09/25/2008 | US20080230465 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content |
| 09/25/2008 | CA2684569A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | CA2684382A1 Treatment of inflammation and/or endotoxic shock |
| 09/25/2008 | CA2681522A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | CA2681038A1 Kinase protein binding inhibitors |
| 09/25/2008 | CA2680876A1 Oral vaccine |
| 09/25/2008 | CA2680708A1 Metal-binding therapeutic peptides |
| 09/25/2008 | CA2680658A1 Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
| 09/25/2008 | CA2680590A1 Combination enzyme therapy for digestion of dietary gluten |
| 09/25/2008 | CA2671303A1 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/24/2008 | EP1972687A1 Polynucleotides and polypeptides of human factor VII gene, SNPs |
| 09/24/2008 | EP1972684A1 Medium for culturing autologous human progenitor stem cells and applications |
| 09/24/2008 | EP1972635A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 09/24/2008 | EP1972346A1 Protein mixture and use thereof in the preparation of a product that is intended for oral or enteral food |
| 09/24/2008 | EP1972345A1 Food product for enteral or oral nutrition |
| 09/24/2008 | EP1972344A1 Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 09/24/2008 | EP1971684A1 Chimaeric fusion protein with superior chaperone and folding activities |
| 09/24/2008 | EP1971619A2 Nogo-b receptor |
| 09/24/2008 | EP1971401A2 METHODS OF USING THE CALCINEURIN A VARIANT Cnaß1 |
| 09/24/2008 | EP1971367A2 Methods and compositions for needleless delivery of binding partners |
| 09/24/2008 | EP1971365A2 Protease compositions for the treatment of damaged tissue |
| 09/24/2008 | EP1971363A1 Combination treatments with gastrin agonists for diabetes and related diseases |
| 09/24/2008 | EP1971362A2 Exendin for treating diabetes and reducing body weight |
| 09/24/2008 | EP1971361A2 Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome |
| 09/24/2008 | EP1971360A2 Treatment of multiple sclerosis using interferon-tau |
| 09/24/2008 | EP1971359A2 Diagnosis and prognosis of colorectal cancer |
| 09/24/2008 | EP1971358A1 A method of treatment |
| 09/24/2008 | EP1971357A2 Use of tpp ii inhibitors in combination with gamma-irradiation for the treatment of cancer |
| 09/24/2008 | EP1971356A2 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 09/24/2008 | EP1971288A2 Micronized device for the delivery of biologically active molecules and methods of use thereof |
| 09/24/2008 | EP1765294B1 Nucleic acid microspheres, production and delivery thereof |
| 09/24/2008 | EP1682012A4 Composition and apparatus for transdermal delivery |
| 09/24/2008 | EP1560558A4 Use of 3-position cyclosporin derivatives for hair growth |
| 09/24/2008 | EP1485483B1 Proteolysis resistant active vegf |
| 09/24/2008 | EP1446139B1 Pharmaceutical composition containing soluble fcgamma receptor iib |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | EP1383578B1 Single dose aromatase inhibitor for treating infertility |
| 09/24/2008 | EP1232254B1 Process for the production of a reversibly inactive acidified plasmin composition |
| 09/24/2008 | EP0979272B1 Strl33, a human fusion accessory factor associated with hiv infection |
| 09/24/2008 | CN101273142A Methods of modulating SMYD3 for treatment of cancer |
| 09/24/2008 | CN101273134A Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes |
| 09/24/2008 | CN101273132A Compositions and methods for treating breast cancer |
| 09/24/2008 | CN101273128A Platelet aggregation inhibitor composition |
| 09/24/2008 | CN101273059A Alpha-MSH analogue of therapeutic activity |
| 09/24/2008 | CN101273057A Bone morphogenesis protein 2 active peptide and production method and application |
| 09/24/2008 | CN101273056A Psma peptide analogues |
| 09/24/2008 | CN101273052A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273042A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101272804A Modulation of granulosa cell apoptosis |
| 09/24/2008 | CN101272803A Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink |
| 09/24/2008 | CN101272802A Antibodies to myostatin |
| 09/24/2008 | CN101272801A 钙结合肽 Calcium binding peptide |
| 09/24/2008 | CN101272800A Cupredoxin derived transport agents and methods of use thereof |
| 09/24/2008 | CN101272694A Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 09/24/2008 | CN101272693A Process for production of fermented milk and fermented milk beverage/food |
| 09/24/2008 | CN101270379A Preparation method for abstracting collagen helical peptide from wood frog tissue |
| 09/24/2008 | CN101270360A XAGE-1 gene and application of its expression production in tumour treatment and diagnosis |